4/26/2022 Evaluating the population-level effects of oxycodone restrictions on prescription opioid utilization in Ontario Rudoler D, Kurdyak P, Gomes T, Huang A, Jones W, Littleford S, Paracha N, Fischer B. Pharmacoepidemiol Drug Saf. 2022; 31(7):769-78. Epub 2022 Apr 26. DOI: https://doi.org/10.1002/pds.5442
2/1/2022 Comparative safety of chronic versus intermittent benzodiazepine prescribing in older adults: a population-based cohort study Davies SJC, Rudoler D, de Oliveira C, Huang A, Kurdyak P, Iaboni A. J Psychopharmacol. 2022; 36(4):460-9. Epub 2022 Feb 1. DOI: https://doi.org/10.1177/02698811211069096
12/28/2021 Emergency department visits for self-harm in adolescents after release of the Netflix series '13 Reasons Why' Sinyor M, Mallia E, de Oliveira C, Schaffer A, Niederkrotenthaler T, Zaheer J, Mitchell R, Rudoler D, Kurdyak P. Aust N Z J Psychiatry. 2021; Dec 28 [Epub ahead of print]. DOI: https://doi.org/10.1177/00048674211065999